Aurobindo Pharma is currently trading at Rs 120.00, up by 8.25 points or 7.38% from its previous closing of Rs 111.75 on the BSE.
The scrip opened at Rs 112.50 and has touched a high and low of Rs 120.75 and Rs 108.10 respectively. So far 401649 shares were traded on the counter.
The BSE group 'A' stock of face value Re 1 has touched a 52 week high of Rs 209.40 on 18-Mar-2011 and a 52 week low of Rs 80.35 on 18-Nov-2011.
Last one week high and low of the scrip stood at Rs 120.75 and Rs 101.05 respectively. The current market cap of the company is Rs 3464.34 crore.
The promoters holding in the company stood at 54.73% while Institutions and Non-Institutions held 30.00% and 15.27% respectively.
Sun Pharmaceuticals up by 2.68%, Lupin up by 1.80%, Dr Reddys Laborotories uo by 0.49%, Fortis Healthcare up by 0.41% and Glenmark Pharmaceuticals up by 0.11% were the other top gainers on BSE “Health Care” space.
Drug firm, Aurobindo Pharma for the quarter ended December 31, 2011, reported consolidated net loss of Rs 28.54 crore against net profit of Rs 188.63 crore for the corresponding period last fiscal. The group’s consolidated net sales rose by 7.74% to Rs 1,284.51 crore during the quarter under review from Rs 1,192.20 crore in the year-ago period.
On a standalone basis, the company posted a net profit of Rs 12.93 crore for the third quarter ended December 31, 2011, as against Rs 183.85 crore in the same period last fiscal. Net sales rose by 3.88% to Rs 1,201.50 crore during the quarter under review from Rs 1,156.61 crore in the year-ago period.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1777.65 |
Dr. Reddys Lab | 1194.55 |
Cipla | 1465.65 |
Lupin | 2043.30 |
Zydus Lifesciences | 944.25 |
View more.. |